Holger Cario

JAK2 haplotype is a major risk factor for the development of myeloproliferative neoplasms

Amy V. Jones, Andrew Chase, Richard T. Silver et al. · Nature Genetics · 2009 · 380 citations · Full text

Hematological Malignancy, Major Risk Factor, Medicine +10

Factors influencing success of clinical genome sequencing across a broad spectrum of disorders

Jenny C. Taylor, Hilary C. Martin, Stefano Lise et al. · Nature Genetics · 2015 · 378 citations · Full text

Sequencing, Psychiatry, Clinical Genome +8

Relative response of patients with myelodysplastic syndromes and other transfusion‐dependent anaemias to deferasirox (ICL670): a 1‐yr prospective study

John B. Porter, Renzo Galanello, Giuseppe Saglio et al. · European Journal Of Haematology · 2007 · 239 citations · Full text

Dihydrofolate Reductase Deficiency Due to a Homozygous DHFR Mutation Causes Megaloblastic Anemia and Cerebral Folate Deficiency Leading to Severe Neurologic Disease

Holger Cario, Desirée E.C. Smith, Henk J. Blom et al. · The American Journal of Human Genetics · 2011 · 137 citations · Full text

Prospective evaluation of patient-reported outcomes during treatment with deferasirox or deferoxamine for iron overload in patients with β-thalassemia

Maria Domenica Cappellini, Mohamed Béjaoui, Leyla Ağaoğlu et al. · Clinical Therapeutics · 2007 · 118 citations

Anemia, Patient-reported Outcomes, Iron Metabolism +4